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Abstract: Composed of a few hundreds of nucleotides, viroids are infectious, circular, non-protein
coding RNAs able to usurp plant cellular enzymes and molecular machineries to replicate and move
in their hosts. Several secondary and tertiary RNA structural motifs have been implicated in the
viroid infectious cycle, but whether modified nucleotides, such as 5C-methylcytosine (m5C), also play
a role has not been deeply investigated so far. Here, the possible existence of m5C in both RNA
polarity strands of potato spindle tuber viroid and avocado sunblotch viroid -which are representative
members of the nucleus- and chloroplast-replicating viroids, respectively- has been assessed at single
nucleotide level. We show that a standard bisulfite protocol efficiently used for identifying m5C in
cellular RNAs may generate false positive results in the case of the highly structured viroid RNAs.
Applying a bisulfite conversion protocol specifically adapted to RNAs with high secondary structure,
no m5C was identified in both polarity strands of both viroids, indicating that this specific nucleotide
modification does not likely play a role in viroid biology.
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1. Introduction
One of the most surprising and fascinating traits emerging in the last decades in molecular biology
is the central role of RNA as regulatory molecule in many and very different biological processes [1].
Primary, secondary and tertiary structural elements have been specifically involved in RNA functionality.
In this context, modified nucleotides have been reported providing functional roles to several cellular
RNAs, including ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), messenger RNAs (mRNAs),
small nuclear RNAs (snRNAs), long non-coding RNAs (lncRNAs) and others [2,3]. Implication of RNA
methylation in the initiation and progression of cancer [4] and in the prevention of recognition of invasive
RNAs by the innate human immune system [5] have also been documented. Methylation, which occurs
in a dynamic manner [6], is one of the most common nucleotide modifications in RNA. Identification of
methylated bases in RNA, including C5-methylcytosine (m5C) and N6-methyladenosine (m6A), dates
back to about 50 years ago [7,8]. Initially, nucleotide modifications were thought to be mainly restricted
to the stable and highly abundant tRNAs and rRNAs. In these cellular RNAs, the modified nucleotides,
including m5C, were mapped in technically demanding studies that support their possible structural
and/or functional roles [9–12]. More recently, the employment of immunoprecipitation combined
with deep sequencing allowed to gain a transcriptome-wide picture of m6A and m5C, unveiling the
relevance of this nucleotide modification in mRNAs [13–16]. Similarly, the improvement of bisulfite
sequencing protocols for RNA [17,18], originally developed for identifying m5C in DNA, allowed to
overcome the main limitation to the extension of this technique to RNA analysis, thus unveiling the
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widespread occurrence of m5C in cellular coding and non-coding RNAs [19,20]. Although functional
roles of RNA methylation are still unclear, these findings showed that the previous reports on the
limited presence of methylated nucleotides in cellular RNAs other than rRNA and tRNAs were mainly
due to technical limitation [2]. The current availability of innovative approaches for RNA methylation
analysis completely changed the general picture on the presence and possible functions of modified
nucleotides in cellular RNAs [21].
Viroids are non-coding RNAs that infect higher plants [22–24]. With a tiny, circular, single-stranded
RNA genome, viroids are able to interact directly with host-encoded molecular factors needed for
their replication and systemic movement. This property is likely due to the viroid ability to mimic
structural features of host RNAs, so that the infectious RNAs can usurp cellular enzymes and molecular
machineries and redirect them to their own replication and spread in the infected host [25]. In agreement
to this prediction, several structural elements of viroid RNAs have been shown to play major roles in
the infectious cycle [26], including tertiary structural motifs that are involved in replication and/or
movement of viroid RNAs [27]. Viroids from different families replicate through alternative rolling
circle mechanisms (symmetric and asymmetric), in which host DNA-dependent RNA polymerases use
viroid RNAs as templates to synthesize complementary RNA molecules. By convention, + polarity
is assigned to the viroid strand that accumulates at higher level in the infected tissues. According
to the replication sites, the rolling circle replication mechanism and other structural and biological
features, viroids are grouped in two families: Pospiviroidae, which groups nuclear viroids replicating
though an asymmetric rolling circle mechanism, and Avsunviroidae, including the chloroplast viroids
that replicate through a symmetric rolling circle mechanism [28,29].
Information on whether viroid RNAs, similarly to other highly-structured cellular RNAs such as
tRNAs or rRNAs, contain modified nucleotides is currently very limited. To our knowledge, the only
attempt to explore this dates back approximately four decades ago to early studies on the primary
and secondary structures of potato spindle tuber viroid (PSTVd) molecule [30]. Based on the notion
that deamination of cytidine to uridine induced by bisulfite treatment depends on the secondary
structure of the RNA -cytidine is fully reactive in single-stranded RNAs, while it is resistant against
modification in base-paired structures [31,32]- RNase fingerprints analyses of bisulfite-treated PSTVd
RNA preparations allowed Domdey and colleagues to conclude that the reactivity of this viroid against
bisulfite-catalyzed modification of cytidines to uridines was consistent with a rod-like secondary
structure composed of short unpaired loop regions connected by short helices [30]. Moreover, modified
nucleotides at the 5′-end group of the oligonucleotides generated by RNase digestions were not
detected in PSTVd RNA preparations tested by fingerprints, thus suggesting the lack of m5C at these
positions in the viroid RNA. This study was limited to the mature circular PSTVd RNA of + polarity.
Moreover, the approach followed by Domdey et al. was unable to detect m5C at a single nucleotide
resolution or in a minor fraction of potentially methylated RNAs. For this reason, in this work,
using updated techniques, we aimed to re-investigate whether viroid RNAs are methylated. First,
we adapted a specific protocol based on RNA bisulfite sequencing to reassess, at a single nucleotide
resolution level, the question regarding the presence of m5C in viroid RNAs. We applied this protocol
to the strands of both polarities of PSTVd and avocado sunblotch viroid (ASBVd), type species of the
families Pospiviroidae and Avsunviroidae, respectively, isolated from infected host plants. Remarkably,
experimental data confirmed the absence of m5C in both strands of both viroids. Moreover, comparison
of this protocol and a previously established protocol to study m5C in mRNAs [18] showed that ours is
more appropriate to analyze the methylation status of viroid and possibly other highly structured RNAs,
which are particularly resistant to bisulfite conversion due to the high level of base-paired cytidines.
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2. Materials and Methods
2.1. Plant Material and RNA Preparations
Leaf samples (10 g) were collected from Nicotiana benthamiana and avocado (Persea americana)
plants infected with PSTVd and ASBVd, respectively, and total nucleic acid were extracted with phenol
and enriched in highly structured RNAs, including also tRNAs and viroid RNAs, by a chromatography
on CF11 cellulose as reported previously [33].
2.2. Bisulfite Sequencing Protocols
Aliquots (3 µg) of viroid enriched RNA preparations were treated with 2 U of RNase-free DNase
(RQ1; Promega, Madison, WI, USA) following the supplier’s protocol. After phenol extraction and
ethanol precipitation, RNA was resuspended in 10 µL of water to perform bisulfite treatment according
to the protocol reported by Pollex et al. [18], hereafter defined as standard (St) protocol. Alternatively,
a modified protocol, herein defined improved (Im), was applied. When the St protocol was used,
42.5 µL of bisulfite mix and 17.5 µL of DNA protect buffer (EpiTect Bisulfite kit, Qiagen, Hilden,
Germany) were added and the resultant mixture was incubated in a thermal cycler to run the following
program: four cycles of 5 min at 70 ◦C, followed by 60 min at 60 ◦C. When the Im protocol was
performed, the incubation in the thermal cycler was as follows: one cycle of 5 min at 80 ◦C, followed by
60 min at 60 ◦C, plus four cycles of 5 min at 75 ◦C, followed by 60 min at 60 ◦C. The reaction mix was
then desalted by size-exclusion chromatography using a Micro Bio-Spin 6 column (Bio-Rad, Hercules,
CA, USA) and the RNA adducts desulfonated by adding 1 volume of 1 M Tris-HCl (pH 9.0) and
incubating at 37 ◦C for 1 h. Converted RNA was precipitated by adding sodium acetate (pH 5.2) to
0.3 M, 1 µg of glycogen, and 3 volumes of 96% ethanol.
2.3. RT-PCR, Cloning and Sequencing
An aliquot (2 µL) of bisulfite converted RNA was used for performing the reverse transcription
with random primers and M-MuLV Reverse Transcriptase (New England BioLabs; Ipswich, UK).
cDNAs were amplified by PCR using Taq DNA polymerase and the Expand High Fidelity PCR system
(Roche Applied Science, Penzberg, Germany) in combination with primers appropriately designed
to minimize cytosine content (Table 1). The amplification products were electrophoresed in a 5%
agarose gel, eluted, ligated in the pGem-T-easy vector (Promega, Madison, WI, USA) according to the
manufacturer protocol, cloned and sequenced with an ABI 3100 XL (Life Technologies, Camarillo, CA,
USA) apparatus.
Table 1. Primers used in this study.
Name seq (5′ to 3′) * Position #
PSTVd_met_1F_plus GGGGCGAGGGTGTTTAG 319–335
PSTVd_met_2R_plus CACTCCCCACCRTCCTTTTTT 138–118
PSTVd_met_3F_plus AAAAAAGGAYGGTGGGGAGTG 118–138
PSTVd_met_4R_plus CTAAACACCCTCRCCCC 335–319
PSTVd_met_5F_minus GAAGAAAGGAAGGGTGAAAA 196–177
PSTVd_met_6R_minus ACCACCCCTCRCCCCCTT 222–239
ASBVd_met_1F_plus GTGGTGAAYTTTTATTAAAAAAATTAG 106–132
ASBVd_met_2R_plus CCACRACTCCTCCTTCTCTCACAA 109–86
ASBVd_met_3F_minus GAGTGAAYTAATTTTTTTAATAAAAGTT 139–112
ASBVd_met_4R_minus TCTTCAATCTCTTRATCACTTC 141–162
HSVd_met_1F_plus GAGAGGYGTGGAGAGAGGG 106–125
HSVd_met_2R_plus CCTCCCTRCCTTATTTTTTCTTT 56–34
tRNA-Asp_1F GTCGTTGTAGTATAGTGG
tRNA-Asp_2R ATCGTTCCCAGGTCAGGG
* R is G or A; Y is C or T; # nucleotide positions related to plus strand of PSTVd variant Nb (AJ634596.1), ASBVd
reference; variant (NC_001410.1) and HSVd reference variant (NC_001351.1).
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3. Results and Discussion
Bisulfite sequencing protocols are generally based on a first step in which RNA preparations are
treated with sodium bisulfite to convert non-methylated Cs to Us, and on a second step in which the
treated RNAs are reverse transcribed, cloned and sequenced to detect converted and unconverted Cs,
likely corresponding to unmethylated and methylated residues, respectively, in the original RNA [17].
In this work, appropriate controls were selected to test the conversion efficiency of non-methylated
Cs to Us by the bisulfite treatment. To this aim, on the one hand, the tRNA-Asp was selected as
an internal control. It is well known that the C at position 38 (C38) of this RNA is methylated,
in contrast to Cs in close positions that are unmethylated [34]. On the other hand, since C-G base-paring
in self-complementary RNA molecules may impair the efficiency of bisulfite conversion [31,32],
an additional control to explore whether lack of bisulfite conversion of some Cs is due to base-pairing
instead of the actual nucleotide methylation was also included. Although RNA modifications in vivo
may further stabilize the RNA secondary structure, we reasoned that a full-length RNA transcript
of hop stunt viroid (HSVd) generated in vitro -which is not methylated- is actually expected to be
fully converted by bisulfite treatment. Unconverted Cs detected in this transcript would suggest an
inefficient treatment or a resistance to the bisulfite conversion, possibly due to local base pairing in the
RNA. HSVd was selected to this aim because (i) it assumes a rod-like conformation similar to those
proposed for PSTVd and ASBVd [35], thus providing a proper control for testing the resistance to
bisulfite conversion caused by inefficient RNA denaturation of highly structured viroid RNAs; and (ii)
its size is similar to those of PSTVd and ASBVd.
To amplify cDNAs from RNAs with converted or unconverted Cs with minimum bias, it is
critical to design the primers in sequence regions lacking Cs. However, this is particularly difficult in
the case of most viroids, which are GC-rich [36]. Therefore, specific primers targeting viroid RNAs
containing no or at the most one C were designed. In this case, the position corresponding to the C
was degenerated to C/T and G/A in the forward and the reverse primers, respectively. Based on this
strategy, two sets of primers were designed to investigate the methylation of the PSTVd RNA of +
polarity, allowing the study of 97% of Cs. In contrast, a single set of primer was designed in the case
of the − polarity strand of PSTVd, both + and − polarities of ASBVd, and + polarity of HSVd RNA,
thus allowing the study of 90, 95, 94 and 79% of Cs contained in the genome of these viroid RNAs,
respectively (Table 1).
When the protocol St was applied, the unconverted C at position 38 of the tRNA-Asp was detected
in all the sequenced clones of N. benthamiana, whereas the proximal Cs were completely converted to
Us, thus suggesting that the protocol is efficient for testing m5C in a tRNA. When the same protocol
was applied to test PSTVd and ASBVd RNAs, several Cs remained unconverted in some of the tested
clones. More specifically, 0.92% and 6.77% of Cs were not converted in a total of 39 and 21 cDNA
clones of the + and − PSTVd strands, respectively (Figure 1, Figure 2 and Figure S1). Although at a
lower extent, unconverted Cs were also detected in both polarity strands of ASBVd (0.30 and 0.93% in
the + and − polarity, respectively) (Figure 1 and Figure S2).
Interestingly, unconverted Cs, although with a different frequency (up to 6.77% of total Cs),
were identified in the clones obtained with all primer sets (Figure 2 and Figure S1). Surprisingly,
one unconverted C was also found in one cDNA clone of the HSVd transcript RNA, where no
methylation was expected (Figure S3). This finding, together with the lack of positions consistently
methylated in the viroid RNAs purified from infected plants, suggested that the resistance to conversion
could not reflect the actual nucleotide methylation status, but being a consequence of strong base pairing.
This hypothesis was further tested by repeating the experiment with the Im protocol that, adopting
more exhaustive denaturing conditions during the bisulfite treatment, was expected to improve the
conversion of Cs in highly structured RNAs. When such a protocol was applied, the methylation
status of Cs in both the tRNA-Asp and HSVd transcripts was as expected, with methylated C38 in the
tRNA and absence of methylated Cs in the in vitro viroid RNA transcript confirmed in all the cloned
cDNAs from bisulfite treated RNA preparations. No unconverted C was detected in the cDNAs of
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both polarity strands of ASBVd by the Im protocol (Figure S2). Moreover, the unconverted Cs in the
clones of PSTVd cDNAs dropped down to 0.08 and 0.07% for the + and − polarity strands, respectively
(Figure 1, Figure 2 and Figure S1). Importantly, in the case of + PSTVd polarity, the single unconverted
C identified with Im protocol in a single clone was in a position different from those detected with
the St protocol. These results show that the Im protocol is better to avoid false positive results on the
presence of m5C in the case of highly structured RNAs like viroids.Viruses 2019, 11, x FOR PEER REVIEW 5 of 9 
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Figure 1. Comparison of RNA bisulfite sequenci by stan ard (St) and improved (Im) protocols.
Percentage of unconverted cytosines detected in + a − strands f potato spindle tuber viroid (PSTVd)
and avocado sunblotch viroid (ASBVd) infecting their natural hosts and in the in vitro transcript of the
+ strand of hop stunt viroid (HSVd) used as a negative control.
Altogether, these results indicate that the Cs of PSTVd and ASBVd are likely unmethylated in
both polarity strands. However, it is important to highlight that this hypothesis could be further tested
by coupling the eff ctive bisulfit conversi n protocol developed here with a high-throughput
sequencing–based analysis of the bisulfite converted RNAs. This approach would explore in
more exhaustive manner the possible presence of minor populations of viroid molecules with
m5C. Altern tively, immun precipitatio of m t ylated RNA with a specific antibody coupled with
high-throughput sequencing could also be useful to this aim [37,38].
On the one hand, our data confirm the previous results on the + polarity strand of PSTVd reported
early after viroid discovery by a le s sensitive technique [30]. On the ther hand, this is the first time
that RNA methylation is investigated in the case of ASBVd, a completely different viroid that replicates
in the chloroplast and belongs to a different family (Avsunviroidae). Our study shows that nuclear
and chloroplast-replicating viroids do not largely differ from each other in respect to methylation and
substantially diminish the possibility that m5C may have a role in viroid biology. In fact, the absence of
methylation in both polarity strands support the conclusion that such a nucleotide modification is very
likely not involved in viroid intracellular trafficking. Methylation of m5C has also bee involved in the
stability of some RNAs [39,40]. However, based on our results, this does not apply to both nuclear and
chloroplast replicating viroids that have been shown to accumulate in vivo as free nucleic acids [41,42],
whose stability is likely provided by their circularity and high degree of secondary structure. Finally,
since it has proposed that RNA methyltransferases appeared during the transition of RNA world to the
present cellular life based on RNA/DNA/protein world [43], the question arises whether the absence of
m5C in viroid RNAs could be considered as an additional indirect evidence of their ancient origin
in the RNA world, besides their small, circular non-protein coding genomes, sometimes endowed of
ribozyme activity [44]. Importantly, our study does not rule out the possibility of other nucleotide
modifications in viroid biology, what remains a fascinating topic waiting for further research.
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IM average 0.12
Figure 2. Bisulfite sequencing of + PSTVd RNAs. Bisulfite cytosine conversion generated by the
standard (St) and the improved (Im) protocols of two + PSTVd fragments amplified with the primer
pairs PSTVd_met_1F_plus/PSTVd_met_2R_plus and PSTVd_met_3F_plus/PSTVd_met_4R_plus (panel
(a,b), respectively). The sequences targeted by the specific primers (salmon background) and the
positions of cytosines in the reference variant PSTVd-Nb (green background) are indicated on the
top. Converted (T, grey background) and unconverted (C, white background) cytosines are reported
for each sequenced clone, the name of which is reported on the left, together with the percentage of
unconverted cytosines.
Supplementary Materials: The following are available online at http://www. dpi.com/1999-4915/11/4/357/
s1, Figure S1 Bisulfite sequencing of − PSTVd RNAs. Bisulfite cytosine conversion generated by the
standard (St) and the improved (Im) protocols of a − PSTVd fragment amplified with the primer pair
PSTVd_met_5F_minus/PSTVd_minus_6R_plus. The sequences targeted by the specific primers (salmon
background) and the positions of cytosines in the reference variant PSTVd-Nb (green background) are indicated
on the top. Convert d (T, grey background) and unconverted (C, white background) cyt sines are reported for
each sequenced clone, the name of which is reported on the left, together with the percentage of unconverted
cytosines. Figure S2 Bisulfite sequencing of + and − ASBVd RNAs. Bisulfite cytosine conversion generated by
the standard (St) and the improved (Im) protocols of + and − PSTVd fragments amplified with the primer pairs
ASBVd_met_1F_plus/ ASBVd _met_2R_plus and ASBVd _met_3F_minus/ ASBVd _met_4R_minus (panel A and
panel B, respectively). The sequences targeted by the specific primers (salmon background) and the positions
of cytosines in the reference variant ASBVd (green b ckground) are indicat d on the top. Converted (T, grey
background) and unconverted (C, white background) cytosines are reported for each sequenced clone, the name of
which is reported on the left, together with the percentage of unconverted cytosines. Figure S3 Bisulfite sequencing
of + HSVd in vitro transcript. Bisulfite cytosine conversion generated by the standard (St) and the improved (Im)
protocols of a + HSVd fragment amplified with the primer pair HSVd_met_1F_plus/HSVd_plus_2R_plus. The
sequences targeted by the specific primers (salmon background) and the positions of cytosines in the reference
va iant HSVd (green backgrou ) are indicat on the t p. Converted (T, grey background) an unconv rted (C,
white background) cytosines are reported for each sequenced clone, the name of which is reported on the left,
together with the percentage of unconverted cytosines.
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